CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-30 | Apuli Maricel Chief Accounting Officer | Sale 10b5-1 | −2,000 | $72.85 | $146K | 120,687 |
| 2026-09-17 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,721 | $69.01 | $602K | 496,965 |
| 2026-09-17 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,279 | $69.57 | $89K | 495,686 |
| 2026-08-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,100 | $83.86 | $679K | 507,586 |
| 2026-08-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,800 | $84.69 | $152K | 505,786 |
| 2026-08-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −100 | $85.65 | $9K | 505,686 |
| 2026-08-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,900 | $81.15 | $154K | 276,407 |
| 2026-08-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −17,279 | $82.21 | $1.4M | 259,128 |
| 2026-08-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −14,602 | $82.99 | $1.2M | 244,526 |
| 2026-08-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,199 | $83.77 | $100K | 243,327 |
| 2026-07-30 | Apuli Maricel Chief Accounting Officer | Sale 10b5-1 | −2,000 | $80.06 | $160K | 127,401 |
| 2026-07-09 | Ellis Andrea Director | Sale 10b5-1 | −17,167 | $84.00 | $1.4M | 22,579 |
| 2026-07-09 | Cook Jennifer E. Director | Sale 10b5-1 | −36,167 | $84.00 | $3.0M | 120,805 |
| 2026-07-09 | Cook Jennifer E. Director | Sale 10b5-1 | −112,422 | $90.00 | $10.1M | 8,383 |
| 2026-06-24 | Cook Jennifer E. Director | Sale 10b5-1 | −37,167 | $70.00 | $2.6M | 8,383 |
| 2026-06-23 | Cook Jennifer E. Director | Sale 10b5-1 | −2,196 | $68.57 | $151K | 8,383 |
| 2026-06-23 | Valantine Hannah Director | Sale 10b5-1 | −2,196 | $68.57 | $151K | 9,259 |
| 2026-06-22 | Valantine Hannah Director | Sale 10b5-1 | −2,808 | $68.00 | $191K | 11,455 |
| 2026-06-15 | Cook Jennifer E. Director | Sale 10b5-1 | −88,737 | $66.62 | $5.9M | 8,092 |
| 2026-06-15 | Cook Jennifer E. Director | Sale 10b5-1 | −1,503 | $67.14 | $101K | 6,589 |
Page 1 of 14 · 272 trades